XM does not provide services to residents of the United States of America.
A
A

AtmosEnergy

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

Atmos Energy reports rise in Q4 profit on higher rates, raises 2025 dividend

Atmos Energy reports rise in Q4 profit on higher rates, raises 2025 dividend Nov 6 (Reuters) - Atmos Energy ATO.N raised its quarterly dividend for 2025 on Wednesday and reported a rise in fourth-quarter profit, as the natural gas utility was helped by higher rates. The company said higher rates in the distribution segment boosted its operating income by $33.4 million in the quarter, helping it report about a 20% rise in the segment at $64.6 million, from the previous year.
A

Atmos Energy Outlook FY Capex USD 3,700 Million

BRIEF-Atmos Energy Outlook FY Capex USD 3,700 Million Nov 06 (Reuters) - Atmos Energy outlook FY EPS USD 7.05-7.25.
A

Atmos Energy Corp <ATO.N> expected to post earnings of 80 cents a share - Earnings Preview

Atmos Energy Corp expected to post earnings of 80 cents a share - Earnings Preview Atmos Energy Corp ATO.N , ATO is expected to show a rise in quarterly revenue when it reports results on November 6 for the period ending September 30 2024 The Dallas Texas-based company is expected to report a 56.4% increase in revenue to $919.06 million from $587.64 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
A

U.S. STOCKS Wave Life Sciences, Dominion Energy, Voyager Therapeutics

BUZZ-U.S. STOCKS ON THE MOVE-Wave Life Sciences, Dominion Energy, Voyager Therapeutics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq were little changed on Wednesday, with declines in heavily weighted technology megacaps limiting gains as investors turned to small-cap and financial stocks after a slew of upbeat bank earnings.
A
A
I
J
S
U
U
G
T
W
A

U.S. STOCKS Wave Life Sciences, Dominion Energy, Voyager Therapeutics

BUZZ-U.S. STOCKS ON THE MOVE-Wave Life Sciences, Dominion Energy, Voyager Therapeutics The Dow regained some lost ground on Wednesday although the S&P 500 and the Nasdaq stumbled, dragged lower by declines in megacap technology stocks, while the broader market gained from upbeat quarterly earnings from banks, notably Morgan Stanley. .N At 11:32 ET, the Dow Jones Industrial Average .DJI was up 0.4% to 42,924.64 at 11:34, pares gain.
A
A
C
D
I
S
J
U
U
U
G
T
W
A

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.